Proteomics International Laboratories Ltd
PIQ
Company Profile
Business description
Proteomics International Laboratories Ltd is a medical technology company specializing in proteomics and precision diagnostics. The company develops and commercializes blood-based tests designed to support earlier and more precise diagnosis and risk assessment. It has established accredited laboratory facilities in Australia and the United States and is headquartered in Perth, Western Australia. Its products portfolio Promarker D, Promarker Eso, Promarker Endo, and OxiDx. It operates in single segment.
Contact
6 Verdun Street
Harry Perkins Institute of Medical Research
Nedlands
PerthWA6009
AUST: +61 893891992
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Proteomics International Laboratories Ltd News & Analysis
funds
Proteomics set for growth, says Kardinia
Kristiaan Rehder explains why the West Australian biotech is among the top performers in the Bennelong Kardinia Capital Absolute Return Fund.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,972.40 | 36.50 | -0.41% |
| CAC 40 | 8,020.31 | 27.38 | -0.34% |
| DAX 40 | 25,864.62 | 116.47 | -0.45% |
| Dow JONES (US) | 51,786.72 | 197.26 | -0.38% |
| FTSE 100 | 10,638.43 | 122.90 | -1.14% |
| HKSE | 23,428.87 | 97.10 | -0.41% |
| NASDAQ | 25,372.01 | 207.65 | 0.83% |
| Nikkei 225 | 61,258.23 | 1,823.63 | -2.89% |
| NZX 50 Index | 13,767.87 | 47.61 | 0.35% |
| S&P 500 | 7,568.92 | 27.52 | 0.36% |
| S&P/ASX 200 | 8,850.70 | 36.10 | -0.41% |
| SSE Composite Index | 3,606.67 | 1.43 | -0.04% |